Novo Nordisk Investigational Site

Arenzano 16011

0 studies enrolling now · 2 studies all time

What they study most

Inflammation, Rheumatoid Arthritis

Studies at this site

• A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Anti-TNFa Biologics — Stopped early
• A Trial of NNC0109-0012, an Anti-IL-20 Biologic, in Patients With Active Rheumatoid Arthritis Who Are Inadequate Responders to Methotrexate — Stopped early